Myriad Genetics Says Study Shows Riskscore Leads To More Accurate Breast Cancer Risk Prediction Than Standard-Of-Care Risk Model
Myriad Genetics Inc MYGN:
MYRIAD GENETICS PATIENT OUTCOMES STUDY SHOWS RISKSCORE LEADS TO MORE ACCURATE BREAST CANCER RISK PREDICTION THAN STANDARD-OF-CARE RISK MODEL